Dan-Dan Wang Selected Research

conteltinib

1/2018	Multikinase Inhibitor CT-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated IGF-1R-YAP Axis.
12/2016	CT-707, a Novel FAK Inhibitor, Synergizes with Cabozantinib to Suppress Hepatocellular Carcinoma by Blocking Cabozantinib-Induced FAK Activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dan-Dan Wang Research Topics

Disease

54	Neoplasms (Cancer) 05/2022 - 11/2011
19	Breast Neoplasms (Breast Cancer) 10/2021 - 01/2015
12	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2011
11	Carcinogenesis 11/2021 - 08/2015
8	Inflammation (Inflammations) 05/2022 - 09/2009
8	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 04/2011
7	Lung Neoplasms (Lung Cancer) 07/2021 - 01/2015
4	Hypoxia (Hypoxemia) 11/2022 - 01/2016
4	Obesity 01/2021 - 01/2018
4	Stomach Neoplasms (Stomach Cancer) 03/2019 - 01/2015
3	COVID-19 04/2022 - 12/2020
3	Cognitive Dysfunction 01/2022 - 01/2019
3	Mitochondrial Diseases (Mitochondrial Disease) 07/2021 - 01/2018
3	Type 2 Diabetes Mellitus (MODY) 02/2018 - 06/2016
3	Alzheimer Disease (Alzheimer's Disease) 06/2016 - 12/2007
2	Infections 04/2022 - 01/2022
2	B-Cell Lymphoma (Lymphoma, B Cell) 04/2022 - 01/2021
2	Virus Diseases (Viral Diseases) 04/2022 - 08/2018
2	Hypertension (High Blood Pressure) 01/2022 - 01/2019
2	Parkinson Disease (Parkinson's Disease) 12/2021 - 10/2021
2	Triple Negative Breast Neoplasms 10/2021 - 01/2021
2	Renal Cell Carcinoma (Grawitz Tumor) 06/2021 - 01/2021
2	Arthritis (Polyarthritis) 05/2021 - 01/2021
2	Experimental Arthritis 02/2021 - 01/2020
2	Osteoporosis 01/2021 - 01/2020
2	Rheumatoid Arthritis 01/2021 - 01/2020
2	Insulin Resistance 01/2021 - 04/2011
2	Pathologic Processes 09/2019 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 03/2018
2	Myocardial Infarction 12/2018 - 01/2018
2	Liver Neoplasms (Liver Cancer) 01/2018 - 01/2015
2	Esophageal Squamous Cell Carcinoma 01/2015 - 10/2013
2	Brain Ischemia (Cerebral Ischemia) 11/2008 - 12/2007
1	Glaucoma 11/2022
1	Ocular Hypertension (Glaucoma, Suspect) 11/2022
1	Colorectal Neoplasms (Colorectal Cancer) 05/2022
1	Alcoholic Fatty Liver 05/2022
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 05/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 03/2022
1	Endometrial Hyperplasia 01/2022
1	Fibroma (Fibromatosis) 01/2022
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2022
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2022

Drug/Important Bio-Agent (IBA)

17	MicroRNAs (MicroRNA)IBA 05/2022 - 10/2016
17	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
16	Proteins (Proteins, Gene)FDA Link 05/2022 - 06/2013
7	Circular RNAIBA 01/2021 - 01/2018
6	Biological ProductsIBA 11/2021 - 06/2014
6	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2021 - 09/2016
5	Pharmaceutical PreparationsIBA 10/2021 - 01/2018
5	Messenger RNA (mRNA)IBA 09/2017 - 05/2009
4	CytokinesIBA 12/2021 - 01/2015
4	Small Interfering RNA (siRNA)IBA 07/2021 - 02/2016
3	EnzymesIBA 11/2021 - 08/2017
3	LigandsIBA 10/2021 - 11/2018
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2021 - 01/2021
3	Formaldehyde (Formol)FDA Link 12/2016 - 09/2009
2	Long Noncoding RNAIBA 05/2022 - 04/2018
2	Antiviral Agents (Antivirals)IBA 04/2022 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 01/2019
2	salicylhydroxamic acid (SHAM)IBA 11/2021 - 05/2009
2	AntigensIBA 10/2021 - 01/2017
2	Thioctic Acid (Lipoic Acid)IBA 01/2020 - 11/2018
2	mangostinIBA 01/2020 - 01/2020
2	LipopolysaccharidesIBA 01/2020 - 05/2017
2	Cholesterol Esters (Cholesteryl Esters)IBA 09/2019 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 03/2019 - 10/2016
2	Polysaccharides (Glycans)IBA 12/2018 - 01/2018
2	LuciferasesIBA 11/2018 - 01/2018
2	conteltinibIBA 01/2018 - 12/2016
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2018 - 02/2016
2	3' Untranslated Regions (3' UTR)IBA 01/2018 - 10/2016
2	ParaffinIBA 12/2016 - 01/2016
2	Amyloid (Amyloid Fibrils)IBA 06/2016 - 06/2016
2	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 02/2016 - 01/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2016 - 01/2016
2	Sorafenib (BAY 43-9006)FDA Link 01/2016 - 01/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 10/2013
1	methanesulfonate salt 2-hydroxy-4,4'-diamidinostilbeneIBA 11/2022
1	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 11/2022
1	nobiletinIBA 11/2022
1	Nucleic AcidsIBA 05/2022
1	Transaminases (Aminotransferases)IBA 05/2022
1	Therapeutic UsesIBA 05/2022
1	LipidsIBA 05/2022
1	di'ao xinxuekangIBA 05/2022
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 04/2022
1	splicing factor 3aIBA 03/2022
1	Estrogens (Estrogen)FDA Link 01/2022
1	AdiponectinIBA 01/2022
1	HDL LipoproteinsIBA 01/2022
1	GTP Phosphohydrolases (GTPases)IBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022

Therapy/Procedure

15	Therapeutics 11/2022 - 09/2009
12	Drug Therapy (Chemotherapy) 10/2021 - 08/2015
3	Immunotherapy 01/2020 - 10/2013
2	Ketogenic Diet 01/2019 - 01/2019
1	Microspheres (Microsphere) 11/2022
1	Curettage 01/2022